Immediate Impact
9 from Science/Nature 63 standout
Citing Papers
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
2024 Standout
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
2023 Standout
Works of Claire Birrell being referenced
A Phase 2b Dose-Ranging Efficacy and Safety Study of Tralokinumab in Adult Patients with Moderate to Severe Atopic Dermatitis
2018
An open‐label, single‐dose bioavailability study of the pharmacokinetics of CAT‐354 after subcutaneous and intravenous administration in healthy males
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Claire Birrell | 494 | 379 | 373 | 13 | 998 | |
| Sarah Dwyer | 392 | 186 | 168 | 22 | 1.1k | |
| Michael W. Nagle | 317 | 55 | 236 | 13 | 912 | |
| Michael S. Goldrich | 378 | 614 | 296 | 11 | 1.1k | |
| Begonia Y. Ho | 607 | 664 | 357 | 26 | 1.3k | |
| Jonathan Feldman | 316 | 221 | 254 | 25 | 964 | |
| Bruce G. McCarthy | 144 | 209 | 497 | 9 | 993 | |
| Catherine A Johnson | 513 | 231 | 340 | 32 | 1.2k | |
| Ludmila V. Deriy | 329 | 108 | 137 | 11 | 1.0k | |
| T. F. Wienker | 606 | 129 | 139 | 25 | 1.1k | |
| Carrie L. Walters | 644 | 656 | 273 | 29 | 1.2k |
All Works
Loading papers...